Biocollection on Peripheral Inflammation
IBIS-PSY
1 other identifier
observational
300
1 country
1
Brief Summary
Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric pathologies commonly used in clinical practice. The study hypothesis is that peripheral inflammatory biomarkers could be common to several psychiatric disorders, in particular psychotic disorders (bipolar disorder, schizophreniform disorder, schizophrenia, depressive episode with psychotic features). The aim of this project is to set up a bio-collection of biological samples (peripheral blood samples) with associated phenotypic data (assessment of various symptoms using standardized scales in patients whose blood is sampled). The setting up of this cohort follows on from work carried out on a PsyCourse cohort also using a transdiagnostic approach in psychiatry, in order to be able to collaborate within a European research project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedStudy Start
First participant enrolled
March 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 2, 2028
April 8, 2024
April 1, 2024
2.4 years
June 28, 2023
April 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Demonstration of the presence of diagnostic biomarkers and biomarkers of severity common to several psychiatric disorders.
Biological analysis of IBIS-PSY biocollection samples
2 hours
Secondary Outcomes (3)
Validation of a patient clustering method separating patients with severe symptoms from those with mild symptoms
2 hours
Replication of a pan-transcriptomic study (A Transcriptome-Wide Association Study (TWAS))
2 hours
Comparison of biomarkers between different psychiatric illnesses in order to develop models based on biological data that can help the physician adjust the diagnosis
2 hours
Study Arms (1)
IBIS-PSY patients
Interventions
Collection of 36 mL of blood
Eligibility Criteria
Participants will be recruited through the doctors who care for them on a regular medical basis, during a consultation or hospitalization in a psychiatric unit. After inclusion, an additional blood sample (4 tubes with a peripheral venous sample) will be taken by nurses from the psychiatric wards caring for the patient, during a blood sample taken as part of the patient's care. The sample will be transported to the Biological Resource Center (CRB) at Nantes University Hospital, where it will be stored along with all other study samples.
You may qualify if:
- Major patient
- Patient with one of the following diagnoses confirmed by a psychiatrist:
- Characterized depressive episode with psychotic features,
- Bipolar disorder type I
- Bipolar disorder type II
- Schizoaffective disorder
- Schizophrenia
- Schizophreniform disorder
- Patient under psychiatric care at Nantes University Hospital
- Patients weighing at least 45kg
- Patient affiliated to a social security scheme or beneficiary of such a scheme
- Patient who has given informed consent to participate in the study
You may not qualify if:
- Pregnant,
- History of cancer in the last 5 years,
- Vaccination within the last 4 weeks,
- Acute or chronic infection,
- Medical history of organ transplant,
- Medical history of autoimmune disease,
- Hearing impairment making it impossible to complete study questionnaires,
- Patient under court protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- CR2TI, INSERM, UMR1064collaborator
Study Sites (1)
Nantes University Hospital
Nantes, 44100, France
Biospecimen
Peripheral blood sampling
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Sauvaget
Nantes University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2023
First Posted
July 7, 2023
Study Start
March 19, 2024
Primary Completion (Estimated)
August 2, 2026
Study Completion (Estimated)
February 2, 2028
Last Updated
April 8, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share